Papers

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis

^a Discipline of Psychiatry, Faculty of Medicine and Health Sciences, University of Newcastle, Callaghan, NSW 2308, Australia, ^b Centre for Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, University of Newcastle

Correspondence to: Dr Hazell.

Abstract

Objective: To examine whether tricyclic antidepressants are superior to placebo in the treatment of child and adolescent depression.
Design: Meta-analysis of 12 randomised controlled trials comparing the efficacy of tricyclic antidepressants with placebo in depressed subjects aged 6-18 years.
Main outcome measures: Most studies employed several depression rating scales. For each study the "best available" measure was chosen by using objective criteria, and individual and pooled effect sizes were calculated as the number of standard deviations by which the change scores for the treatment groups exceeded those for the control groups. Where authors had reported numbers "responding" to treatment we calculated individual and pooled ratios for the odds of improvement in treated compared with control subjects.
Results: From the six studies presenting data which enabled an estimation of effect size the pooled effect size was 0.35 standard deviations (95% confidence interval of -0.16 to 0.86) indicating no significant benefit of treatment. From the five studies presenting data on the number of "responders" in each group, the ratio of the odds of a response in the treated compared with the control subjects was calculated and the pooled odds ratio was 1.08 (95% confidence interval of 0.53 to 2.17); again indicating no significant benefit of treatment. The pooled sample had more than an 80% chance of detecting a treatment effect of 0.5 standard deviations or greater. There was an inverse relation between study quality and estimated treatment effect.
Conclusions: Tricyclic antidepressants appear to be no more effective than placebo in the treatment of depression in children and adolescents.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Place of tricyclics in depression of young people is not proved

Ian Anderson
BMJ 1995 311: 390. [Extract] [Full Text]

This article has been cited by other articles:

• Tsapakis*, E. M., Soldani*, F., Tondo, L., Baldessarini, R. J. (2008). Efficacy of antidepressants in juvenile depression: meta-analysis. Br. J. Psychiatry 193: 10-17 [Abstract] [Full text]  
• Leslie, L. K., Newman, T. B., Chesney, P. J., Perrin, J. M. (2005). The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients. Pediatrics 116: 195-204 [Abstract] [Full text]  
• Caballero, J., Nahata, M. C. (2005). Selective serotonin-reuptake inhibitors and suicidal ideation and behavior in children. Am J Health Syst Pharm 62: 864-867 [Full text]  
• Ryan, E. P., Redding, R. E. (2004). A Review of Mood Disorders Among Juvenile Offenders. Psychiatr. Serv. 55: 1397-1407 [Abstract] [Full text]  
• Naqvi, S. (2004). Review of Child and Adolescent Psychiatry. Focus 2: 529-540 [Abstract] [Full text]  
• Martin, A., Young, C., Leckman, J. F., Mukonoweshuro, C., Rosenheck, R., Leslie, D. (2004). Age Effects on Antidepressant-Induced Manic Conversion. Arch Pediatr Adolesc Med 158: 773-780 [Abstract] [Full text]  
• Crethar, H. C., Snow, K., Carlson, J. (2004). It's All in the Family: Family Counseling for Depressed Children. The Family Journal 12: 222-229 [Abstract]  
• Wagner, K. D., Robb, A. S., Findling, R. L., Jin, J., Gutierrez, M. M., Heydorn, W. E. (2004). A Randomized, Placebo-Controlled Trial of Citalopram for the Treatment of Major Depression in Children and Adolescents. Am. J. Psychiatry 161: 1079-1083 [Abstract] [Full text]  
• Clark, A. F. (2004). Incidences of New Prescribing by British Child and Adolescent Psychiatrists: a Prospective Study Over 12 Months. J Psychopharmacol 18: 115-120 [Abstract]  
• Ramchandani, P. (2004). Treatment of major depressive disorder in children and adolescents. BMJ 328: 3-4 [Full text]  
• Wagner, K. D., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M. S., Childress, A., Donnelly, C., Deas, D. (2003). Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder: Two Randomized Controlled Trials. JAMA 290: 1033-1041 [Abstract] [Full text]  
• Rutter, M. (2002). The Interplay of Nature, Nurture, and Developmental Influences: The Challenge Ahead for Mental Health. Arch Gen Psychiatry 59: 996-1000 [Abstract] [Full text]  
• Brent, D. A., Birmaher, B. (2002). Adolescent Depression. NEJM 347: 667-671 [Full text]  
• Jacobson, L., Churchill, R., Donovan, C., Garralda, E., Fay, J. (2002). Tackling teenage turmoil: primary care recognition and management of mental ill health during adolescence. Fam Pract 19: 401-409 [Abstract] [Full text]  
• Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Soeken, K., Boles, M., Lynch, F. (2002). Rising Prevalence of Antidepressants Among US Youths. Pediatrics 109: 721-727 [Abstract] [Full text]  
• Harrington, R. (2001). Depression, suicide and deliberate self-harm in adolescence. Br Med Bull 57: 47-60 [Abstract] [Full text]  
• Straus, S. E, McAlister, F. (2001). Applying the results of trials and systematic reviews to our individual patients. Evid. Based Ment. Health 4: 6-7 [Full text]  
• Ambrosini, P. J. (2000). A Review of Pharmacotherapy of Major Depression in Children and Adolescents. Psychiatr. Serv. 51: 627-633 [Abstract] [Full text]  
• Rushton, J. L., Clark, S. J., Freed, G. L. (2000). Primary Care Role in the Management of Childhood Depression: A Comparison of Pediatricians and Family Physicians. Pediatrics 105: 957-962 [Abstract] [Full text]  
• Pandey, G. N., Dwivedi, Y., Pandey, S. C., Teas, S. S., Conley, R. R., Roberts, R. C., Tamminga, C. A. (1999). Low Phosphoinositide-Specific Phospholipase C Activity and Expression of Phospholipase C {beta}1 Protein in the Prefrontal Cortex of Teenage Suicide Subjects. Am. J. Psychiatry 156: 1895-1901 [Abstract] [Full text]  
• James, A. (1999). Resistant Depression in Childhood and Adolescence. Clin Child Psychol Psychiatry 4: 483-491 [Abstract]  
• Harrington, R., Whittaker, J., Shoebridge, P., Campbell, F. (1998). Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. BMJ 316: 1559-1563 [Abstract] [Full text]  
• Fleming, J. (1998). Fluoxetine decreased depressive symptoms in children and adolescents with non-psychotic major depressive disorder. Evid. Based Ment. Health 1: 49-49 [Full text]  
• Anderson, I. (1995). Place of tricyclics in depression of young people is not proved. BMJ 311: 390-390 [Full text]  
• Perry, A, Persaud, R (1995). Variability among studies should be investigated. BMJ 310: 1604a-1604 [Full text]  
• (1995). TRICYCLIC ANTIDEPRESSANTS FOR CHILD AND ADOLESCENT DEPRESSION: A META-ANALYSIS. JWatch General 1995: 3-3 [Full text]